Track Sai Life Sciences Ltd. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Sai Life Sciences Ltd. SAILIFE.NS · Stock Open Sai Life Sciences Ltd. in new tab

1333.40 INR
P/E
80.77
EPS
16.45
P/B
11.31
ROE
15.13
Target Price
1275.00 INR
Loading chart...
Key Metrics
Earnings dateAug. 6, 2026
P/E80.77
EPS16.45
Book Value117.47
Price to Book11.31
Debt/Equity11.61
% Insiders37.961%
Growth
Revenue Growth0.04%
Earnings Growth0.18%
Estimates
Forward P/E54.11
Forward EPS24.55
Target Mean Price1275.00

DCF Valuation

Tweak assumptions to recompute fair value for Sai Life Sciences Ltd. (SAILIFE.NS)
Currency: INR
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Sai Life Sciences Ltd. Logo Sai Life Sciences Ltd. Analysis (SAILIFE.NS)

Is Sai Life Sciences Ltd. a good investment? Sai Life Sciences Ltd. (SAILIFE.NS) is currently trading at 1333.40 INR. Market analysts have a consensus price target of 1275.00 INR. This suggests the asset is currently trading above analyst expectations.

In terms of valuation, the stock trades at a P/E ratio of 80.77. This high multiple suggests investors have priced in significant future growth expectations.

Earnings Schedule: Sai Life Sciences Ltd. is expected to release its next earnings report on Aug. 6, 2026. The market consensus estimate for Forward EPS is 24.55.

Investor FAQ

Does Sai Life Sciences Ltd. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Sai Life Sciences Ltd.?

Sai Life Sciences Ltd. is classified as a Stock.

When is the next earnings date?

The next earnings date is projected to be Aug. 6, 2026. The company currently has a trailing EPS of 16.45.

Company Profile

Sai Life Sciences Limited operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally. It provides medicinal chemistry, pharmacokinetics, manufacturing, and contract development services. The company was formerly known as SAI Advantium Pharma Limited and changed its name to Sai Life Sciences Limited in July 2006. Sai Life Sciences Limited was incorporated in 1999 and is based in Hyderabad, India.

Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion